Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant Claudin 3 antibody

The Human Monoclonal anti-Claudin 3 antibody (Clone 12B2) (ABIN7608426) specifically detects Claudin 3 in ELISA. The antibody is reactive with Human samples.
Catalog No. ABIN7608426
$691.59
Plus shipping costs $50.00
100 μL
Shipping to: United States
Delivery in 2 to 3 Business Days

Quick Overview for Recombinant Claudin 3 antibody (ABIN7608426)

Target

See all Claudin 3 (CLDN3) Antibodies
Claudin 3 (CLDN3)

Antibody Type

Recombinant Antibody

Reactivity

  • 64
  • 20
  • 15
  • 3
  • 3
Human

Host

  • 56
  • 11
  • 1
Human

Clonality

  • 44
  • 24
Monoclonal

Conjugate

  • 35
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Claudin 3 antibody is un-conjugated

Application

  • 41
  • 23
  • 18
  • 16
  • 15
  • 11
  • 4
  • 3
  • 2
  • 1
ELISA

Clone

12B2
  • Expression System

    HEK-293F Cells

    Purpose

    Cldn3 Recombinant Antibody

    Characteristics

    The Cldn3 Recombinant Antibody (Species: Human) has been validated for the following applications: ELISA.

    Purification

    Affinity-Chromatography

    Immunogen

    Recombinant Human Cldn3 Protein

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Preservative: 0.03 % Proclin 300, Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    Claudin 3 (CLDN3)

    Alternative Name

    CLDN3

    UniProt

    O15551

    Pathways

    Hepatitis C
You are here:
Chat with us!